1Life Healthcare (NASDAQ:ONEM) Shares Up 5%

1Life Healthcare, Inc. (NASDAQ:ONEM)’s stock price shot up 5% during mid-day trading on Friday . The company traded as high as $36.06 and last traded at $35.44. 2,243,918 shares were traded during trading, an increase of 50% from the average session volume of 1,498,587 shares. The stock had previously closed at $33.75.

A number of brokerages recently issued reports on ONEM. Canaccord Genuity boosted their price target on 1Life Healthcare from $39.00 to $41.00 and gave the company a “buy” rating in a report on Wednesday, November 11th. Credit Suisse Group boosted their price target on 1Life Healthcare from $37.00 to $40.00 and gave the company an “outperform” rating in a report on Wednesday, November 11th. JPMorgan Chase & Co. reiterated an “overweight” rating and set a $43.00 target price (up previously from $40.00) on shares of 1Life Healthcare in a report on Wednesday, November 11th. Truist upped their target price on 1Life Healthcare from $30.00 to $36.00 in a report on Friday, August 14th. Finally, Morgan Stanley upped their target price on 1Life Healthcare from $35.00 to $41.00 and gave the stock an “overweight” rating in a report on Wednesday, November 11th. Five equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. 1Life Healthcare presently has an average rating of “Buy” and an average target price of $37.43.

The company has a debt-to-equity ratio of 0.45, a quick ratio of 7.47 and a current ratio of 7.50. The business has a 50-day moving average price of $30.98 and a 200 day moving average price of $31.54. The stock has a market capitalization of $4.71 billion and a P/E ratio of -12.48.

1Life Healthcare (NASDAQ:ONEM) last issued its quarterly earnings results on Sunday, November 15th. The company reported ($0.13) EPS for the quarter, topping analysts’ consensus estimates of ($0.19) by $0.06. The company had revenue of $101.67 million during the quarter, compared to the consensus estimate of $86.16 million. During the same period in the prior year, the firm earned ($0.82) earnings per share. The business’s revenue for the quarter was up 46.0% compared to the same quarter last year. As a group, research analysts forecast that 1Life Healthcare, Inc. will post -0.91 earnings per share for the current fiscal year.

In related news, CEO Amir Dan Rubin sold 111,135 shares of the company’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $29.55, for a total value of $3,284,039.25. Following the transaction, the chief executive officer now directly owns 405,187 shares of the company’s stock, valued at approximately $11,973,275.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CTO Kimber D. Lockhart sold 15,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 18th. The shares were sold at an average price of $33.42, for a total value of $501,300.00. Following the completion of the transaction, the chief technology officer now directly owns 52,349 shares in the company, valued at $1,749,503.58. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,074,790 shares of company stock worth $33,026,275.

A number of hedge funds have recently added to or reduced their stakes in ONEM. Hound Partners LLC bought a new stake in 1Life Healthcare in the second quarter worth about $4,831,000. BlackRock Inc. lifted its stake in 1Life Healthcare by 287.5% in the third quarter. BlackRock Inc. now owns 6,005,348 shares of the company’s stock worth $170,315,000 after purchasing an additional 4,455,397 shares during the last quarter. FIL Ltd lifted its stake in 1Life Healthcare by 99.0% in the second quarter. FIL Ltd now owns 4,271,566 shares of the company’s stock worth $155,143,000 after purchasing an additional 2,125,089 shares during the last quarter. 12 West Capital Management LP bought a new stake in 1Life Healthcare in the third quarter worth about $39,698,000. Finally, Vanguard Group Inc. lifted its stake in 1Life Healthcare by 99.2% in the second quarter. Vanguard Group Inc. now owns 2,782,511 shares of the company’s stock worth $101,060,000 after purchasing an additional 1,385,487 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

About 1Life Healthcare (NASDAQ:ONEM)

1Life Healthcare, Inc operates a membership-based primary care platform. The company has developed a healthcare membership model based on direct consumer enrollment, as well as employer sponsorship. Its membership model includes seamless access to digital health services paired with inviting in-office care routinely covered under health insurance programs.

Read More: How Do Front-End Loads Impact an Investment?

Receive News & Ratings for 1Life Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 1Life Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.